Malignant Transformation of CD4+T Lymphocytes Mediated by Oncogenic Kinase NPM/ALK Recapitulates IL-2–Induced Cell Signaling and Gene Expression Reprogramming-Reference-Cited by-同舟云学术

Malignant Transformation of CD4+T Lymphocytes Mediated by Oncogenic Kinase NPM/ALK Recapitulates IL-2–Induced Cell Signaling and Gene Expression Reprogramming

Published:2013-11-11 Issue:12 Volume:191 Page:6200-6207
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Marzec Michal,Halasa Krzysztof,Liu Xiaobin,Wang Hong Y.,Cheng Mangeng,Baldwin Donald,Tobias John W.,Schuster Stephen J.,Woetmann Anders,Zhang Qian,Turner Suzanne D.,Ødum Niels,Wasik Mariusz A.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference47 articles.

1. Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy

2. The anaplastic lymphoma kinase in the pathogenesis of cancer

3. Anaplastic Lymphoma Kinase (ALK)-Induced Malignancies: Novel Mechanisms of Cell Transformation and Potential Therapeutic Approaches

4. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5).

5. Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anaplastic Large-cell Lymphoma in Children: State of the Art in 2023;Journal of Pediatric Hematology/Oncology;2024-06-24

2. Chimeric kinase ALK induces expression of NAMPT and selectively depends on this metabolic enzyme to sustain its own oncogenic function;Leukemia;2023-09-29

3. Induction of Transcriptional Inhibitor HES1 and the Related Repression of Tumor-Suppressor TXNIP Are Important Components of Cell-Transformation Program Imposed by Oncogenic Kinase NPM-ALK;The American Journal of Pathology;2022-08

4. NIPA (Nuclear Interaction Partner of ALK) Is Crucial for Effective NPM-ALK Mediated Lymphomagenesis;Frontiers in Oncology;2022-05-13

5. Anaplastic Large Cell Lymphoma: Molecular Pathogenesis and Treatment;Cancers;2022-03-24